• No results found

Circulating and Mucosal Antibodies to Citrullinated Antigens in Rheumatoid Arthritis

N/A
N/A
Protected

Academic year: 2021

Share "Circulating and Mucosal Antibodies to Citrullinated Antigens in Rheumatoid Arthritis"

Copied!
2
0
0

Loading.... (view fulltext now)

Full text

(1)

Linköping University Medical Dissertation No. 1404

ANNA SVÄRD

Circulating and Mucosal Antibodies

to Citrullinated Antigens

in Rheumatoid Arthritis

2014 A N N A S VÄ R D

(2)

Linköping University Medical Dissertation No. 1404 Department of Clinical and Experimental Medicine

Faculty of Health Sciences, Linköping University 581 85 Linköping, Sweden www.liu.se 2014 A N N A S VÄ R D

References

Related documents

• To analyze the activation pattern in the parabrachial nucleus after immune challenge with particular reference to its enkephalinergic cells. • To examine the presence

Department of Clinical and Experimental Medicine Linköping University, SE-581 85, Sweden.

The studies presented in this thesis are part of a body of research in Resilience Engineering (RE) that in the past decade has developed theories, methods and models, and

[r]

Faculty of Health Sciences Linköping University SE-581 85 Linköping, Sweden.

Previous studies have demonstrated that the presence of rheumatoid factors (RFs) of IgM, IgG, and IgA class [2,3] CCP = cyclic citrullinated peptide; CI = confidence interval; IQR

Disease activity reflected by median levels of erythrocyte sedimentation rate (ESR) and serum C-reactive protein (CRP) at diagnosis of rheumatoid arthritis, and presence of

Inhibition of the mitochondrial permeability transition pore (mPTP) in response to convulxin and thrombin was shown to reduce most of the features of coated platelets; Annexin